全文获取类型
收费全文 | 285875篇 |
免费 | 8961篇 |
国内免费 | 366篇 |
专业分类
耳鼻咽喉 | 2699篇 |
儿科学 | 9516篇 |
妇产科学 | 5547篇 |
基础医学 | 30510篇 |
口腔科学 | 3865篇 |
临床医学 | 23280篇 |
内科学 | 54373篇 |
皮肤病学 | 1820篇 |
神经病学 | 26394篇 |
特种医学 | 12717篇 |
外国民族医学 | 3篇 |
外科学 | 46770篇 |
综合类 | 3908篇 |
现状与发展 | 1篇 |
一般理论 | 85篇 |
预防医学 | 26858篇 |
眼科学 | 5805篇 |
药学 | 16417篇 |
中国医学 | 775篇 |
肿瘤学 | 23859篇 |
出版年
2023年 | 461篇 |
2022年 | 808篇 |
2021年 | 1975篇 |
2020年 | 1069篇 |
2019年 | 1882篇 |
2018年 | 23877篇 |
2017年 | 18814篇 |
2016年 | 21010篇 |
2015年 | 3002篇 |
2014年 | 3921篇 |
2013年 | 5664篇 |
2012年 | 13894篇 |
2011年 | 27983篇 |
2010年 | 22635篇 |
2009年 | 15094篇 |
2008年 | 26026篇 |
2007年 | 28868篇 |
2006年 | 7819篇 |
2005年 | 9504篇 |
2004年 | 10404篇 |
2003年 | 11026篇 |
2002年 | 9122篇 |
2001年 | 1314篇 |
2000年 | 1183篇 |
1999年 | 1171篇 |
1998年 | 1641篇 |
1997年 | 1442篇 |
1996年 | 1180篇 |
1995年 | 1148篇 |
1994年 | 1025篇 |
1993年 | 881篇 |
1992年 | 785篇 |
1991年 | 785篇 |
1990年 | 746篇 |
1989年 | 690篇 |
1988年 | 624篇 |
1987年 | 655篇 |
1986年 | 598篇 |
1985年 | 669篇 |
1984年 | 843篇 |
1983年 | 873篇 |
1982年 | 1084篇 |
1981年 | 995篇 |
1980年 | 980篇 |
1979年 | 539篇 |
1978年 | 625篇 |
1977年 | 654篇 |
1976年 | 570篇 |
1975年 | 493篇 |
1974年 | 436篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Julia H. Vermylen Gordon J. Wood Elaine R. Cohen Jeffrey H. Barsuk William C. McGaghie Diane B. Wayne 《Journal of pain and symptom management》2019,57(3):682-687
Introduction
Physician communication impacts patient outcomes. However, communication skills, especially around difficult conversations, remain suboptimal, and there is no clear way to determine the validity of entrustment decisions. The aims of this study were to 1) describe the development of a simulation-based mastery learning (SBML) curriculum for breaking bad news (BBN) conversation skills and 2) set a defensible minimum passing standard (MPS) to ensure uniform skill acquisition among learners.Innovation
An SBML BBN curriculum was developed for fourth-year medical students. An assessment tool was created to evaluate the acquisition of skills involved in a BBN conversation. Pilot testing was completed to confirm improvement in skill acquisition and set the MPS.Outcomes
A BBN assessment tool containing a 15-item checklist and six scaled items was developed. Students' checklist performance improved significantly at post-test compared to baseline (mean 65.33%, SD = 12.09% vs mean 88.67%, SD = 9.45%, P < 0.001). Students were also significantly more likely to have at least a score of 4 (on a five-point scale) for the six scaled questions at post-test. The MPS was set at 80%, requiring a score of 12 items on the checklist and at least 4 of 5 for each scaled item. Using the MPS, 30% of students would require additional training after post-testing.Comments
We developed a SBML curriculum with a comprehensive assessment of BBN skills and a defensible competency standard. Future efforts will expand the mastery model to larger cohorts and assess the impact of rigorous education on patient care outcomes. 相似文献2.
3.
4.
Marlene L Hauck Susan M LaRue William P Petros Jean M Poulson Daohai Yu Ivan Spasojevic Amy F Pruitt Allison Klein Beth Case Donald E Thrall David Needham Mark W Dewhirst 《Clinical cancer research》2006,12(13):4004-4010
PURPOSE: To determine the maximum tolerated dose, dose-limiting toxicities, and pharmacokinetic characteristics of doxorubicin encapsulated in a low temperature sensitive liposome (LTSL) when given concurrently with local hyperthermia to canine solid tumors. EXPERIMENTAL DESIGN: Privately owned dogs with solid tumors (carcinomas or sarcomas) were treated. The tumors did not involve bone and were located at sites amenable to local hyperthermia. LTSL-doxorubicin was given (0.7-1.0 mg/kg i.v.) over 30 minutes during local tumor hyperthermia in a standard phase I dose escalation study. Three treatments, given 3 weeks apart, were scheduled. Toxicity was monitored for an additional month. Pharmacokinetics were evaluated during the first treatment cycle. RESULTS: Twenty-one patients were enrolled: 18 with sarcomas and 3 with carcinomas. Grade 4 neutropenia and acute death secondary to liver failure, possibly drug related, were the dose-limiting toxicities. The maximum tolerated dose was 0.93 mg/kg. Other toxicities, with the possible exception of renal damage, were consistent with those observed following free doxorubicin administration. Of the 20 dogs that received > or = 2 doses of LTSL-doxorubicin, 12 had stable disease, and 6 had a partial response to treatment. Pharmacokinetic variables were more similar to those of free doxorubicin than the marketed liposomal product. Tumor drug concentrations at a dose of 1.0 mg/kg averaged 9.12 +/- 6.17 ng/mg tissue. CONCLUSION: LTSL-doxorubicin offers a novel approach to improving drug delivery to solid tumors. It was well tolerated and resulted in favorable response profiles in these patients. Additional evaluation in human patients is warranted. 相似文献
5.
6.
7.
8.
9.
10.